<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36298819</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>TDP-43 Toxicity in Yeast Is Associated with a Reduction in Autophagy, and Deletions of <i>TIP41</i> and <i>PBP1</i> Counteract These Effects.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2264</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14102264</ELocationID><Abstract><AbstractText>When human TDP-43 is overexpressed in yeast it is toxic and forms cytoplasmic aggregates. The mechanism of this toxicity is unknown. Genetic screens for TDP-43 toxicity modifiers in the yeast system previously identified proteins, including PBP1, that enhance TDP-43 toxicity. The determination in yeast that deletion of <i>PBP1</i> reduces TDP-43 toxicity while overexpression enhances toxicity, led to the discovery that its human homolog, <i>ATXN2</i>, is associated with ALS risk. Thus, the yeast system has relevance to human disease. We now show that deletion of a new yeast gene, <i>tip41</i><i>&#x394;</i>, likewise suppresses TDP-43 toxicity. We also found that TDP-43 overexpression and toxicity is associated with reduced autophagy. This is consistent with findings in other systems that increasing autophagy reduces TDP-43 toxicity and is in contrast to a report of enhanced autophagy when TDP-43 was overexpressed in yeast. Interestingly, we found that deletions of <i>PBP1</i> and <i>TIP41</i>, which reduced TDP-43 toxicity, eliminated TDP-43's inhibition of autophagy. This suggests that toxicity of TDP-43 expressed in yeast is in part due to its inhibition of autophagy and that deletions of <i>PBP1</i> and <i>TIP41</i> may reduce TDP-43 toxicity by preventing TDP-43 from inhibiting autophagy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sei-Kyoung</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Nevada, Reno, NV 89557, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sangeun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Nevada, Reno, NV 89557, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liebman</LastName><ForeName>Susan W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Nevada, Reno, NV 89557, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM136229</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5R35GM136229-03</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C116076">PBP1 protein, S cerevisiae</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029701">Saccharomyces cerevisiae Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="Y">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029701" MajorTopicYN="Y">Saccharomyces cerevisiae Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PBP1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">TIP41</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">yeast</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; the collection, analyses, or interpretation of data; the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>1</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36298819</ArticleId><ArticleId IdType="pmc">PMC9607128</ArticleId><ArticleId IdType="doi">10.3390/v14102264</ArticleId><ArticleId IdType="pii">v14102264</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meriin A.B., Zhang X., He X., Newnam G.P., Chernoff Y.O., Sherman M.Y. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J. Cell Biol. 2002;157:997&#x2013;1004. doi: 10.1083/jcb.200112104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200112104</ArticleId><ArticleId IdType="pmc">PMC2174031</ArticleId><ArticleId IdType="pubmed">12058016</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokhale K.C., Newnam G.P., Sherman M.Y., Chernoff Y.O. Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model. J. Biol. Chem. 2005;280:22809&#x2013;22818. doi: 10.1074/jbc.M500390200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500390200</ArticleId><ArticleId IdType="pubmed">15824100</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., McCaffery J.M., Lindquist S., Gitler A.D. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA. 2008;105:6439&#x2013;6444. doi: 10.1073/pnas.0802082105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802082105</ArticleId><ArticleId IdType="pmc">PMC2359814</ArticleId><ArticleId IdType="pubmed">18434538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju S., Tardiff D.F., Han H., Divya K., Zhong Q., Maquat L.E., Bosco D.A., Hayward L.J., Brown R.H., Jr., Lindquist S., et al. A yeast model of FUS/TLS-dependent cytotoxicity. PLoS Biol. 2011;9:e1001052. doi: 10.1371/journal.pbio.1001052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001052</ArticleId><ArticleId IdType="pmc">PMC3082520</ArticleId><ArticleId IdType="pubmed">21541368</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryndushkin D., Ihrke G., Piermartiri T.C., Shewmaker F. A yeast model of optineurin proteinopathy reveals a unique aggregation pattern associated with cellular toxicity. Mol. Microbiol. 2012;86:1531&#x2013;1547. doi: 10.1111/mmi.12075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/mmi.12075</ArticleId><ArticleId IdType="pubmed">23078282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryndushkin D., Wickner R.B., Shewmaker F. FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis. Protein Cell. 2011;2:223&#x2013;236. doi: 10.1007/s13238-011-1525-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1525-0</ArticleId><ArticleId IdType="pmc">PMC4875312</ArticleId><ArticleId IdType="pubmed">21452073</ArticleId></ArticleIdList></Reference><Reference><Citation>Fushimi K., Long C., Jayaram N., Chen X., Li L., Wu Y.J. Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy. Protein Cell. 2011;2:41&#x2013;149. doi: 10.1007/s13238-011-1014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1014-5</ArticleId><ArticleId IdType="pmc">PMC3093303</ArticleId><ArticleId IdType="pubmed">21327870</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Finkbeiner S. Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: Disease-associated pathways. Rev. Neurosci. 2010;21:251&#x2013;272. doi: 10.1515/REVNEURO.2010.21.4.251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/REVNEURO.2010.21.4.251</ArticleId><ArticleId IdType="pubmed">21086759</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Skibinski G., Korb E., Rao E.J., Wu J.Y., Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. Off. J. Soc. Neurosci. 2010;30:639&#x2013;649. doi: 10.1523/JNEUROSCI.4988-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4988-09.2010</ArticleId><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z., Lopez-Erauskin J., Baughn M.W., Zhang O., Drenner K., Sun Y., Freyermuth F., McMahon M.A., Beccari M.S., Artates J.W., et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 2019;22:180&#x2013;190. doi: 10.1038/s41593-018-0293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Armakola M., Hart M.P., Gitler A.D. TDP-43 toxicity in yeast. Methods. 2011;53:238&#x2013;245. doi: 10.1016/j.ymeth.2010.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2010.11.006</ArticleId><ArticleId IdType="pmc">PMC3073690</ArticleId><ArticleId IdType="pubmed">21115123</ArticleId></ArticleIdList></Reference><Reference><Citation>Peggion C., Massimino M.L., Stella R., Bortolotto R., Agostini J., Maldi A., Sartori G., Tonello F., Bertoli A., Lopreiato R. Nucleolin Rescues TDP-43 Toxicity in Yeast and Human Cell Models. Front. Cell. Neurosci. 2021;15:625665. doi: 10.3389/fncel.2021.625665.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.625665</ArticleId><ArticleId IdType="pmc">PMC8072491</ArticleId><ArticleId IdType="pubmed">33912014</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.K., Hong J.Y., Arslan F., Kanneganti V., Patel B., Tietsort A., Tank E.M.H., Li X., Barmada S.J., Liebman S.W. Overexpression of the essential Sis1 chaperone reduces TDP-43 effects on toxicity and proteolysis. PLoS Genet. 2017;13:e1006805. doi: 10.1371/journal.pgen.1006805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006805</ArticleId><ArticleId IdType="pmc">PMC5460882</ArticleId><ArticleId IdType="pubmed">28531192</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Rahman M.H., Park D., Jo M., Kim H.J., Suk K. Identification of Genetic Modifiers of TDP-43: Inflammatory Activation of Astrocytes for Neuroinflammation. Cells. 2021;10:676. doi: 10.3390/cells10030676.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030676</ArticleId><ArticleId IdType="pmc">PMC8003223</ArticleId><ArticleId IdType="pubmed">33803845</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley M.D., Gitler A.D. Yeast genetic screen reveals novel therapeutic strategy for ALS. Rare Dis. 2013;1:e24420. doi: 10.4161/rdis.24420.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rdis.24420</ArticleId><ArticleId IdType="pmc">PMC3933050</ArticleId><ArticleId IdType="pubmed">25002991</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero W., Shatunov A., Stahl D., Shoai M., van Rheenen W., Jones A.R., Al-Sarraj S., Andersen P.M., Bonini N.M., Conforti F.L., et al. ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol. Aging. 2017;51:178.e1&#x2013;178.e9. doi: 10.1016/j.neurobiolaging.2016.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.11.010</ArticleId><ArticleId IdType="pmc">PMC5302215</ArticleId><ArticleId IdType="pubmed">28017481</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker L.A., Huang B., Bieri G., Ma R., Knowles D.A., Jafar-Nejad P., Messing J., Kim H.J., Soriano A., Auburger G., et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. 2017;544:367&#x2013;371. doi: 10.1038/nature22038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22038</ArticleId><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Auburger G., Sen N.E., Meierhofer D., Basak A.N., Gitler A.D. Efficient Prevention of Neurodegenerative Diseases by Depletion of Starvation Response Factor Ataxin-2. Trends Neurosci. 2017;40:507&#x2013;516. doi: 10.1016/j.tins.2017.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2017.06.004</ArticleId><ArticleId IdType="pubmed">28684172</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn C.D., Jensen R.E. Suppression of a defect in mitochondrial protein import identifies cytosolic proteins required for viability of yeast cells lacking mitochondrial DNA. Genetics. 2003;165:35&#x2013;45. doi: 10.1093/genetics/165.1.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/genetics/165.1.35</ArticleId><ArticleId IdType="pmc">PMC1462761</ArticleId><ArticleId IdType="pubmed">14504216</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.S., Kato M., Wu X., Litsios A., Sutter B.M., Wang Y., Hsu C.H., Wood N.E., Lemoff A., Mirzaei H., et al. Yeast Ataxin-2 Forms an Intracellular Condensate Required for the Inhibition of TORC1 Signaling during Respiratory Growth. Cell. 2019;177:697&#x2013;710.e617. doi: 10.1016/j.cell.2019.02.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.02.043</ArticleId><ArticleId IdType="pmc">PMC6752053</ArticleId><ArticleId IdType="pubmed">30982600</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibiger C., Deisel J., Aufschnaiter A., Ambros S., Tereshchenko M., Verheijen B.M., Buttner S., Braun R.J. TDP-43 controls lysosomal pathways thereby determining its own clearance and cytotoxicity. Hum. Mol. Genet. 2018;27:1593&#x2013;1607. doi: 10.1093/hmg/ddy066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy066</ArticleId><ArticleId IdType="pubmed">29474575</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Serio A., Arjun A., Bilican B., Daub A., Ando D.M., Tsvetkov A., Pleiss M., Li X., Peisach D., et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 2014;10:677&#x2013;685. doi: 10.1038/nchembio.1563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1563</ArticleId><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I.F., Guo B.S., Liu Y.C., Wu C.C., Yang C.H., Tsai K.J., Shen C.K. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl. Acad. Sci. USA. 2012;109:15024&#x2013;15029. doi: 10.1073/pnas.1206362109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206362109</ArticleId><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes L.R., Kalab P. Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD. Neurother. J. Am. Soc. Exp. Neurother. 2022 doi: 10.1007/s13311-022-01260-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-022-01260-5</ArticleId><ArticleId IdType="pmc">PMC9587158</ArticleId><ArticleId IdType="pubmed">35790708</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose J.K., Huang C.C., Shen C.K. Regulation of autophagy by neuropathological protein TDP-43. J. Biol. Chem. 2011;286:44441&#x2013;44448. doi: 10.1074/jbc.M111.237115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.237115</ArticleId><ArticleId IdType="pmc">PMC3247982</ArticleId><ArticleId IdType="pubmed">22052911</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zhang X., Song L., Le W. Autophagy dysregulation in amyotrophic lateral sclerosis. Brain Pathol. 2012;22:110&#x2013;116. doi: 10.1111/j.1750-3639.2011.00546.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2011.00546.x</ArticleId><ArticleId IdType="pmc">PMC8029048</ArticleId><ArticleId IdType="pubmed">22150926</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies F.M., Fleming A., Caricasole A., Bento C.F., Andrews S.P., Ashkenazi A., Fullgrabe J., Jackson A., Jimenez Sanchez M., Karabiyik C., et al. Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities. Neuron. 2017;93:1015&#x2013;1034. doi: 10.1016/j.neuron.2017.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.01.022</ArticleId><ArticleId IdType="pubmed">28279350</ArticleId></ArticleIdList></Reference><Reference><Citation>Manogaran A.L., Fajardo V.M., Reid R.J., Rothstein R., Liebman S.W. Most, but not all, yeast strains in the deletion library contain the [PIN(+)] prion. Yeast. 2010;27:159&#x2013;166. doi: 10.1002/yea.1740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/yea.1740</ArticleId><ArticleId IdType="pmc">PMC3717406</ArticleId><ArticleId IdType="pubmed">20014044</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.K., Arslan F., Kanneganti V., Barmada S.J., Purushothaman P., Verma S.C., Liebman S.W. Overexpression of a conserved HSP40 chaperone reduces toxicity of several neurodegenerative disease proteins. Prion. 2018;12:16&#x2013;22. doi: 10.1080/19336896.2017.1423185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1423185</ArticleId><ArticleId IdType="pmc">PMC5871033</ArticleId><ArticleId IdType="pubmed">29308690</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S., Gitler A.D., Lindquist S. A suite of Gateway cloning vectors for high-throughput genetic analysis in Saccharomyces cerevisiae. Yeast. 2007;24:913&#x2013;919. doi: 10.1002/yea.1502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/yea.1502</ArticleId><ArticleId IdType="pmc">PMC2190539</ArticleId><ArticleId IdType="pubmed">17583893</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman F.G., Hicks J.B. Methods in Yeast Genetics. Cold Spring Harbor Press; Plainview, NY, USA: 1986.</Citation></Reference><Reference><Citation>Yorimitsu T., Zaman S., Broach J.R., Klionsky D.J. Protein kinase A and Sch9 cooperatively regulate induction of autophagy in Saccharomyces cerevisiae. Mol. Biol. Cell. 2007;18:4180&#x2013;4189. doi: 10.1091/mbc.e07-05-0485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e07-05-0485</ArticleId><ArticleId IdType="pmc">PMC1995722</ArticleId><ArticleId IdType="pubmed">17699586</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorimitsu T., He C., Wang K., Klionsky D.J. Tap42-associated protein phosphatase type 2A negatively regulates induction of autophagy. Autophagy. 2009;5:616&#x2013;624. doi: 10.4161/auto.5.5.8091.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5.5.8091</ArticleId><ArticleId IdType="pmc">PMC2738980</ArticleId><ArticleId IdType="pubmed">19223769</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer R.C., Chami A.A., de Assis D.R., Vourc&#x2019;h P., Andres C.R., Corcia P., Lanznaster D., Blasco H. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: A resolution in sight? Brain A J. Neurol. 2019;142:1176&#x2013;1194. doi: 10.1093/brain/awz078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz078</ArticleId><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Yang Y.S., Sutter B.M., Wang Y., McKnight S.L., Tu B.P. Redox State Controls Phase Separation of the Yeast Ataxin-2 Protein via Reversible Oxidation of Its Methionine-Rich Low-Complexity Domain. Cell. 2019;177:711&#x2013;721.e718. doi: 10.1016/j.cell.2019.02.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.02.044</ArticleId><ArticleId IdType="pmc">PMC6752730</ArticleId><ArticleId IdType="pubmed">30982603</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacinto E., Guo B., Arndt K.T., Schmelzle T., Hall M.N. TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway. Mol. Cell. 2001;8:1017&#x2013;1026. doi: 10.1016/S1097-2765(01)00386-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(01)00386-0</ArticleId><ArticleId IdType="pubmed">11741537</ArticleId></ArticleIdList></Reference><Reference><Citation>Prouteau M., Desfosses A., Sieben C., Bourgoint C., Lydia Mozaffari N., Demurtas D., Mitra A.K., Guichard P., Manley S., Loewith R. TORC1 organized in inhibited domains (TOROIDs) regulate TORC1 activity. Nature. 2017;550:265&#x2013;269. doi: 10.1038/nature24021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24021</ArticleId><ArticleId IdType="pmc">PMC5640987</ArticleId><ArticleId IdType="pubmed">28976958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>